JSJunichi Suzuki

Junichi Suzuki

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Junichi Suzuki has a total of 56 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Clinical significance of coefficient of variation in continuous glucose monitoring for glycemic management in children and adolescents with type 1 diabetes

    by Tatsuhiko Urakami, Hiroki Terada, Satomi Tanabe, Yusuke Mine, Masako Aoki, Ryoji Aoki, Junichi Suzuki, Ichiro Morioka

    Aims/Introduction: Coefficient of variation (CV) is an indicator for glucose variability in continuous glucose monitoring (CGM), and the target threshold of %CV in type 1 diabetes is proposed to be ≤36%. This study aimed to evaluate the clinical significance of CV in children and adolescents with type 1 diabetes.Materials and Methods: Participants included 66 children with type 1 diabetes. A total of 48 participants were treated with multiple daily injections of insulin, and 18 with continues subcutaneous insulin infusion, using intermittently scanned CGM. The frequencies of the CGM metrics and glycosylated hemoglobin values were examined, and the significance of a threshold %CV of 36% was evaluated.Results: The mean frequencies in time in range (TIR), time below range, %CV and the mean glycosylated hemoglobin value were 59.3 ± 16.1, 4.0 ± 3.5, 39.3 ± 6.2 and 7.3 ± 0.8%, respectively. The frequencies of participants who achieved a TIR >70% and a %CV of ≤36% were 24.1 and 27.3%, respectively. A total of 18 participants with a %CV of ≤36% had significantly higher TIR, lower time below range and lower glycosylated hemoglobin than the 48 with a %CV of >36% (72.6 ± 12.6 vs 52.4 ± 13.6, 2.4 ± 1.9 vs 4.6 ± 3.6, 6.9 ± 0.8 vs 7.4 ± 0.7%, respectively).Conclusions: Children and adolescents with type 1 diabetes using intermittently scanned CGM had difficulties in achieving the recommended targets of TIR and CV. However, the target %CV of ≤36% seems to be an appropriate indicator for assessing glycemic control and risk of hypoglycemia in pediatric patients with type 1 diabetes with any treatment.


  • Open Access

    A multicenter, open‐label, single‐arm trial of the long‐term safety of empagliflozin treatment for refractory diabetes mellitus with insulin resistance (EMPIRE‐02)

    by Yushi Hirota, Yasumasa Kakei, Junta Imai, Hideki Katagiri, Ken Ebihara, Jun Wada, Junichi Suzuki, Tatsuhiko Urakami, Takashi Omori, Wataru Ogawa

    Aims/Introduction: Insulin resistance syndrome and lipoatrophic diabetes are rare conditions characterized by the development of treatment‐refractory diabetes with severe insulin resistance. We recently conducted a 24 week, multicenter, single‐arm trial (EMPIRE‐01) that demonstrated a certain level of effectiveness and safety of empagliflozin for these conditions. To evaluate treatment safety over a longer period, we have now performed an additional 28 week trial (EMPIRE‐02) that followed on from EMPIRE‐01.Materials and Methods: The primary and secondary outcomes were safety and efficacy evaluations, respectively. All eight subjects of the EMPIRE‐01 trial participated in EMPIRE‐02.Results: Twenty adverse events (AEs) were recorded among five individuals during the combined 52 week treatment period of both trials. Whereas one case of chronic hepatitis B was moderate in severity, all other AEs were mild. There were thus no serious AEs or events necessitating discontinuation or suspension of treatment or a reduction in drug dose. Whereas ketoacidosis or marked increases in serum ketone body levels were not observed, the mean body mass of the subjects was decreased slightly after completion of EMPIRE‐02. The improvement in mean values of glycemic parameters observed in EMPIRE‐01 was not sustained in EMPIRE‐02, mostly because of one individual whose parameters deteriorated markedly, likely as a result of nonadherence to diet therapy. The improvement in glycemic parameters was sustained during EMPIRE‐02 after exclusion of this subject from analysis.Conclusions: Empagliflozin demonstrated a certain level of safety and efficacy for the treatment of insulin resistance syndrome and lipoatrophic diabetes over 52 weeks, confirming its potential as a therapeutic option.


  • Open Access

    Comparison of the clinical effects of intermittently scanned and real‐time continuous glucose monitoring in children and adolescents with type 1 diabetes: A retrospective cohort study

    by Tatsuhiko Urakami, Hiroki Terada, Kei Yoshida, Remi Kuwabara, Yusuke Mine, Masako Aoki, Yasuko Shoji, Junichi Suzuki, Ichiro Morioka

    Aims/Introduction: The aim of the study was to compare two continuous glucose monitoring (CGM) systems, intermittently scanned CGM (isCGM) and real‐time CGM (rtCGM), to determine which system achieved better glycemic control in pediatric patients.Materials and Methods: We carried out a retrospective cohort study of children and adolescents with type 1 diabetes, and compared the time in range (70–180 mg/dL), time below range (180 mg/dL), and estimated glycated hemoglobin levels between patients on isCGM and rtCGM.Results: Of the 112 participants, 76 (67.9%) used isCGM and 36 (32.1%) used rtCGM for glycemic management. Patients on rtCGM had significantly greater time in range (57.7 ± 12.3% vs 52.3 ± 12.3%, P = 0.0368), and had significantly lower time below range (4.3 ± 2.7% vs 10.2% ± 5.4%, P < 0.001) than those on isCGM, but there was no significant difference in the time above range (37.4 ± 12.9% vs 38.0% ± 12.5%, P = 0.881) or the glycosylated hemoglobin A1c levels (7.4 ± 0.9% vs 7.5 ± 0.8%, P = 0.734) between the two groups.Conclusions: Pediatric patients with type 1 diabetes on rtCGM also showed more beneficial effects for increase of time in range, with a notable reduction of time below range compared with those on isCGM. Real‐time CGM might provide better glycemic control than isCGM in children with type 1 diabetes.


  • Open Access

    HIGH TEMPERATURE BEHAVIOR OF H-SHAPED STEEL BEAM WITH CIRCULAR OPENINGS IN WEB (PART 2): REPRODUCTION OF EXPERIMENTS BY FINITE ELEMENT ANALYSIS AND ANALYSIS OF FIRE RESISTANCE UNDER VARIOUS CONDITIONS

    by Unggi Yoon, Haruhiko Murakami, Mamoru Kohno, Jun-Ichi Suzuki

    In order to investigate the behavior of protected steel beams with multiple circular openings at high temperatures under fire conditions, full-scale load-heating experiments were discussed in the previous paper. In this paper, an analysis procedure using ABAQUS FEM code to accurately reproduce the experimental results of the previous paper is developed. Furthermore, using the developed analysis method, perforated H-beams with various hole diameters, hole spacings, and fire protection thicknesses were analyzed. The findings of this paper are as follows: 1) In order to analyze the behavior of perforated H-shaped steel beams at high temperatures using a general-purpose finite element code, an analysis method including boundary conditions, an FEM mesh model, and an appropriate method for setting the mechanical and thermal properties of the materials used, such as steel, and thermal conditions including configuration factors of various surfaces, has been developed. 2) The behavior of a protected perforated H-shaped steel beam with multiple circular openings having the diameter of half of the beam height under ISO 834 standard heating, as reported in the previous paper, was analyzed using the analysis method described above. 3) It was found that the fire resistance improved as the hole spacing increased, but the improvement became smaller when the hole spacing exceeded 2.5 times the hole diameter. 4) The results of the analysis with the hole diameter varied in the range of 1/2 to 1/4 of the beam height and the hole spacing was either 1.5 or 2.5 times the hole diameter showed that there was no significant difference in fire resistance when the hole spacing/hole diameter ratio was the same. 5) As for the fire protection thickness, when the hole spacing/hole diameter ratio is 1.5, the fire performance of the beam does not approach that of a non-hole beam of the same specification even if the fire protection thickness is doubled. However, when the hole spacing/hole diameter ratio is 2.5, the fire resistance of the beam is almost equal to that of the non-hole beam when the fire protection thickness is increased by a factor of 1.4. 6) When holes with a diameter of less than 1/2 the beam length are installed in the web at intervals of 2.5 times the hole diameter or more, the fire resistance of the beam can be maintained at least as high as that of a non-hole beam, even if the inner surface is not fire protected, if the thickness of the fire protection is not less than 1.4 times the thickness of the non-hole beam.

  • Open Access

    Frequent scanning using flash glucose monitoring contributes to better glycemic control in children and adolescents with type 1 diabetes

    by Tatsuhiko Urakami, Kei Yoshida, Remi Kuwabara, Yusuke Mine, Masako Aoki, Junichi Suzuki, Ichiro Morioka

    Aims/Introduction: We examined the impact of scanning frequency with flash glucose monitoring on glycemic control in children and adolescents with type 1 diabetes.Materials and Methods: The study included 85 patients, aged 14.0 ± 0.5 years, with type 1 diabetes. The median time in the target glucose range (TIR) and glycosylated hemoglobin (HbA1c) values were 50.0 ± 1.4% and 7.5 ± 0.1%, respectively.Results: The median scanning frequency using flash glucose monitoring was 12.0 ± 0.4 times/day. Scanning frequency showed a significant positive correlation with TIR and an inverse correlation with HbA1c. Scanning frequency was identified to be the determinant of TIR and HbA1c by using multivariate analysis. The participants whose scanning frequency was 12 times/day were categorized as the high‐frequency group (n = 45). Patients in the high‐frequency group were more likely to be treated with insulin pumps compared with those in the low‐frequency group; however, this difference was not significant (21.3 vs 5.3%, P = 0.073). The high‐frequency group showed significantly greater TIR than the low‐frequency group (57 ± 1.6 vs 42 ± 1.7%, P = 0.002). Furthermore, the high‐frequency group showed significantly lower HbA1c levels than the low‐frequency group (6.8 ± 0.1 vs 8.0 ± 0.1%, P < 0.001).Conclusions: These findings showed that patients with a higher scanning frequency had better glycemic control, with greater TIRs and lower HbA1c levels, compared with those with a lower scanning frequency. Scanning frequency of >12 times/day might contribute to better glycemic outcomes in real‐world practice in children with type 1 diabetes.


  • Greater insulin resistance in short children born small‐for‐gestational age than in children with growth hormone deficiency at the early period of growth hormone therapy

    by Junichi Suzuki, Tatsuhiko Urakami, Ichiro Morioka

    Background: We compared insulin resistance and glucose metabolism during growth hormone (GH) therapy between 43 short children born small‐for‐gestational age (SGA) and 42 children identify as growth hormone deficiency (GHD).Methods: The study compared fasting plasma glucose (FPG), fasting immunoreactive insulin (IRI) and homeostasis model assessment insulin resistance index (HOMA‐IR) during 24‐month GH therapy between the two groups.Results: Mean FPG, fasting IRI, and HOMA‐IR values at 3‐month GH therapy were significantly higher than those before and at 12‐ and 24‐month GH therapy in both groups. These markers were significantly higher in short children born SGA than GHD children until 12‐month GH therapy but were not different at 24‐month GH therapy in both groups.Conclusions: The increased secretion of insulin observed in short children born SGA might be a compensatory mechanism for the prevention of hyperglycemia that can progress to diabetes mellitus. However, these metabolic markers gradually declined after 3 months of GH therapy and returned to baseline values at 24 months. These results suggest that short children born SGA have greater insulin resistance than GHD children at the early period of GH therapy, however, increased insulin resistance is improved over a long period.


  • Association between scanning frequency of flash glucose monitoring and continuous glucose monitoring‐derived glycemic makers in children and adolescents with type 1 diabetes

    by Junichi Suzuki, Tatsuhiko Urakami, Kei Yoshida, Remi Kuwabara, Yusuke Mine, Masako Aoki, Ichiro Morioka

    Background: We assessed the association between scanning frequency of flash glucose monitoring (FGM) and continuous glucose monitoring (CGM)‐derived glycemic markers in children and adolescents with type 1 diabetes.Methods: Subjects consisted of 85 children and adolescents with type 1 diabetes using FGM. We assessed the association between scanning frequencies of FGM‐ and CGM‐derived metrics: Time in range (TIR) (70‐180 mg/dL), time below range (TBR) (180 mg/dL), and other glycemic markers – laboratory‐measured HbA1c and CGM‐estimated glucose and HbA1c (eA1c) levels in the subjects.Results: The mean number of scans was 11.5 ± 3.5 (5–20) times per day, and scanning was most frequently conducted during a period of 18–24 h. Scanning frequency showed significant positive correlation with TIR (r = 0.719, P < 0.0001) and inverse correlation with time above range (r = −0.743, P < 0.0001), but did not correlate with TBR. There were also significant inverse correlations between scanning frequency and glucose, HbA1c, and eA1c levels (r = −0.765, −0.815, and −0.793, respectively, P < 0.0001).Conclusions: Frequent glucose testing with FGM decreased hyperglycemia with increased TIR, but did not reduce TBR. Coping with a rapid fall of glucose and unexpected hypoglycemia with more advanced technology might contribute to a reduction in TBR.